Features
Latest World Pharmaceuticals Feature
It is often the final stage of a drug’s journey that can be the...
> read more
Room for improvement: cold-chain pharmaceuticals Huge investment and attention have been spent on improving and standardising the safe shipment of cold chain pharmaceuticals, but to what extent is there a danger of all this...
Medicine for the planet: sustainable packaging The primary job of packaging is to ensure the safety of pharmaceutical products, but the wrong choice of material can be detrimental to a company’s sustainability goals – especially if...
Calculating risk Last year, the International Society for Pharmaceutical Engineering released the second edition of ‘Baseline Guide: Risk-Based Manufacture of Pharmaceutical Products’, to help manage...
Packing heat: temperature control during storage and distribution Uncontrolled temperature fluctuation during distribution and storage can be a significant source of revenue loss, and pharmaceutical companies are increasingly looking for new ways...
Keep on track and trace: benefit of traceability in the supply chain With regulatory requirements evolving fast, much of the discussion around track and trace revolves around meeting compliance deadlines. However, there is a strong business case for...
Getting ready for serialisation: 'track and trace' solutions EU and US deadlines for serialisation, and track and trace are fast approaching, but many pharmaceutical companies remain dangerously unprepared. With time running out, Patrick...
Combinational pride: the complexity of mixing drugs, devices and biologics As combination products become more prevalent, they pose a number of regulatory challenges. Essentially, it isn’t always clear whether a product should be regulated as a drug, biologic...
A winning combination: digital solutions for medical treatments The market for combination products is rapidly expanding, in part due to advances in digital health technology. World Pharmaceutical Frontiers considers the directions these...
With data in mind: best practice clinical trials management As the outsourcing of clinical trials increases, maintaining best practice in data management when working with a contract research organisation is of the utmost importance. Grace...
Sourcing on a global scale As more clinical trials are conducted across different regions, it is important for the industry to address the problems in the clinical supply chain that could affect the...
The legal matter: controlled substances Working with controlled substances can pose a challenge for clinical investigators. Erica Madison looks at some of the key regulatory considerations and hears from industry leaders on...
Out in the cold chain It is often the final stage of a drug’s journey that can be the most hazardous. Ensuring the cold chain is not broken means understanding a number of variables and options....
Rules of engagement: patient-centricity and patient management How do we design trials to be more patient-centric and what can be done to encourage patient engagement among clinical trial teams that works for all involved? Thérèse Johnsen,...
Digital trailblazers Industry 4.0 promises great things for the pharmaceutical sector, but reaping the rewards of this new technology comes with a number of challenges. Henk Mollee, senior director...
Check the small print: smart-labelling Technology is transforming clinical trials, especially when it comes to packaging. The latest developments allow clinicians to fit huge amounts of information on their labels,...
Anti-cancer collaboration Experts at The University of Texas MD Anderson Cancer Center have been talking about its innovative approach to cancer research. By connecting pharma companies with academics, rather...
Trial separation: Brexit effect on pharma In 2019, the UK will end its membership of the EU, and with it a series of mechanisms that bind it to a continent-wide set of regulations for clinical trials. Emma Cave, a professor...
Sweet harmony: clinical trials protocol template The increasing complexity of clinical trials, combined with the inexperience of many investigators who write the protocol templates, has long caused concerns. In 2017, US...
Silver linings:cloud-based technology for clinical trials For pharma and biotech companies, cloud-based technology is poised to deliver simplicity and enhanced sponsor-provider relationships to the costly and prolonged clinical trials...
View all features A-Z
